BMC Cancer

official impact factor 3.15

Open Access Research article

Protein p16 as a marker of dysplastic and neoplastic alterations in cervical epithelial cells

Galina Volgareva1*, Larisa Zavalishina2, Yulia Andreeva2, Georgy Frank2, Ella Krutikova3, Darya Golovina1, Alexander Bliev1, Dimitry Spitkovsky4, Valeriya Ermilova5 and Fjodor Kisseljov1

Author Affiliations

1 Institute of Carcinogenesis, N.N.Blokhin Cancer Research Center, Russian Academy of Medical Sciences, Moscow 115478, Russia

2 P.A.Gertzen Institute of Oncology, Russian Ministry of Health, Moscow 125284, Russia

3 Chair of Obstetrics and Gynecology, Ukrainian Medical Stomatological Academy, Poltava, Ukraine

4 Kourion Therapeutics AG, Langenfeld, Germany

5 Institute of Clinical Oncology, N.N.Blokhin Cancer Research Center, Russian Academy of Medical Sciences, Moscow 115478, Russia

For all author emails, please log on.

BMC Cancer 2004, 4:58 doi:10.1186/1471-2407-4-58

Published: 31 August 2004

Additional files

Additional File 1:

Data on high risk HPV genome detection by PCR in CIN I and CIN II samples. the data are presented on high-risk HPV genetic material detection in 9 CIN I and 9 CIN II samples.

Format: XLS Size: 16KB Download file

This file can be viewed with: Microsoft Excel Viewer

Open Data